In Synovial Sarcoma (SS), characterized by the fusion of the SS18 gene to either SSX1, SSX2, or SSX4, the expression of FOXM1 associates with poor prognosis and correlates with cell-cycle genes (Table 1; Figure 3). Here, SSX2 is linked to synovial sarcoma.